NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Press Release Stockholm, 30 November […]
Read moreMonth: November 2020
Philips expands its healthcare customer services portfolio with the introduction of integrated Cybersecurity Services
November 30, 2020 Philips partners with CyberMDX, a leader in connected medical device security, to provide vendor-neutral solutions to protect connected medical systems and devices Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the Philips Cybersecurity Services for seamlessly integrating and enhancing strategic security solutions […]
Read morePhilips introduces next generation of Advanced Visualization Workspace – IntelliSpace Portal 12 – with AI capabilities at RSNA 2020
November 30, 2020 Next generation of Philips’ advanced radiology visualization platform leverages image post-processing and artificial intelligence (AI) to deliver quantitative clinical insights, drive increased diagnostic confidence, simplify workflows, and reduce time-to-report New features include AI algorithms for lung nodule detection, cardiac functional analysis, and quantification of pulmonary infiltrates associated with COVID-19 patients Intelligent, automated […]
Read moreBombardier Appoints Bart Demosky Executive Vice President and Chief Financial Officer
MONTREAL, Nov. 30, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) announced today the appointment of Bart Demosky as Executive Vice President and Chief Financial Officer, effective immediately. Bart will report to Éric Martel, President and Chief Executive Officer, Bombardier Inc., replacing John Di Bert who will be leaving the Company. “We are very excited to […]
Read moreAlgernon Pharmaceuticals Announces Enrollment of Final Patient in its Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that the final patient has been enrolled in its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The aggregate […]
Read moreNovavax Announces COVID-19 Vaccine Clinical Development Progress
Pivotal Phase 3 trial in United Kingdom completes enrollment Phase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update […]
Read moreThai PM says he will respect ruling of Constitutional Court, whatever the outcome
Thailand’s Prime Minister Prayut Chan-o-cha said today that he will accept and respect the verdict of the Constitutional Court, expected this Wednesday, whatever the outcome
Read moreProgressive Movement to be investigated for actions related to local elections
Thailand’s Election Commission has set up a committee to investigate the conduct of the Progressive Movement, which is accused by political activist Srisuwan Janya of
Read moreFour prominent Thai protest leaders face lèse majesté charges
Four prominent protest leaders of the Ratsadon group reported to Chanasongkhram police station in Bangkok today (Monday), to acknowledge lèse majesté charges related to protests
Read moreWHO Director-General’s opening remarks at the media briefing on COVID-19 – 30 November 2020
Last week saw the first decline in newly-reported cases globally since September. This is no time for complacency, especially with the holiday season approaching in
Read more